TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.24
+19.26 (27.92%)
At close: Nov 6, 2026, 4:00 PM EST
88.00
-0.24 (-0.27%)
After-hours: Nov 6, 2026, 7:58 PM EST
TransMedics Group Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 727.65 | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 |
Revenue Growth | 28.48% | 37.13% | 82.74% | 158.53% | 208.83% | 18.03% |
Gross Profit Gross Profit Growth | 426.43 | 362.81 | 262.08 | 154.09 | 65.27 | 21.16 |
Operating Income Operating Income Growth | 86.45 | 108.58 | 37.5 | -1.52 | -31.44 | -39.43 |
Net Income Net Income Growth | 144.45 | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 |
Earnings Per Share EPS Growth | 3.88 | 4.87 | 1.01 | -0.77 | -1.23 | -1.60 |
EPS Growth | 52.80% | 382.53% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States Lung United States Lung Growth | 8.33 | 13.44 | 15.76 | 10.55 | 7.97 | 9.84 |
United States Heart United States Heart Growth | 118.59 | 111.84 | 96.66 | 59.08 | 29.9 | 10.1 |
United States Liver United States Liver Growth | 564.13 | 459.42 | 309.46 | 151.72 | 46.17 | 1.92 |
All Other Countries Lung All Other Countries Lung Growth | 2.4 | 1.42 | 1.93 | 1.27 | 0.88 | 0.82 |
All Other Countries Heart All Other Countries Heart Growth | 18.79 | 14.17 | 13.2 | 14.01 | 8.45 | 7.58 |
All Other Countries Liver All Other Countries Liver Growth | 1.14 | 1.11 | 0.16 | 0.1 | 0.09 | - |
Other Service Other Service Growth | 13.83 | 4.1 | 4.38 | 4.89 | - | - |
Revenue (Total) Revenue (Total) Growth | 727.65 | 605.49 | 441.54 | 241.62 | 93.46 | 30.26 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 492.96 | 488.37 | 336.65 | 394.81 | 201.18 | 92.45 |
Total Debt Total Debt Growth | 866.9 | 519.28 | 518.29 | 515.95 | 67.56 | 43.8 |
Net Cash (Debt) Net Cash Growth | -373.94 | -30.91 | -181.64 | -121.13 | 133.63 | 48.65 |
Net Cash Growth | - | - | - | - | 174.66% | -46.53% |
Net Cash Per Share Net Cash Per Share Growth | -10.03 | -0.76 | -5.16 | -3.73 | 4.52 | 1.76 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 112.36 | 192.84 | 48.8 | -13.03 | -45.82 | -28.86 |
Capital Expenditures CapEx Growth | -67.66 | -59.25 | -129.74 | -151.85 | -11.91 | -3.52 |
Free Cash Flow Free Cash Flow Growth | 44.7 | 133.59 | -80.94 | -164.88 | -57.72 | -32.38 |
Free Cash Flow Growth | -62.95% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.60% | 59.92% | 59.36% | 63.77% | 69.84% | 69.92% |
Operating Margin | 11.88% | 17.93% | 8.49% | -0.63% | -33.64% | -130.29% |
Pretax Margin | 10.12% | 17.76% | 8.10% | -11.04% | -38.70% | -145.99% |
Profit Margin | 19.85% | 31.43% | 8.03% | -10.36% | -38.77% | -146.11% |
FCF Margin | 6.14% | 22.06% | -18.33% | -68.24% | -61.76% | -107.01% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.77 | 21.85 | 59.01 | - | - | - |
Forward PE | 43.68 | 47.40 | 56.70 | - | - | - |
P/FCF Ratio | 68.57 | 31.12 | - | - | - | - |
PS Ratio | 4.21 | 6.87 | 4.74 | 10.67 | 21.08 | 17.58 |